Your browser doesn't support javascript.
loading
Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study.
Li, Yu; Qi, Yue; Sun, Mingshen; Zhai, Changbin; Wei, Wenbin; Zhang, Fengju.
Afiliación
  • Li Y; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China.
  • Qi Y; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China.
  • Sun M; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China.
  • Zhai C; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China.
  • Wei W; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China.
  • Zhang F; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, 100730, China. zhangfj126@126.com.
Ophthalmol Ther ; 12(2): 853-866, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36542255

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ophthalmol Ther Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ophthalmol Ther Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido